Novel Therapeutics for Familial Chylomicronemia Syndrome.

Curr Atheroscler Rep · 2025 · PMC12011915 · PMID 40257687

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The 80-mg group achieved a significant 43.5% TG reduction at six months (P < 0.001), while the 50-mg dose did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.